Literature DB >> 21157376

Defective glial maturation in vanishing white matter disease.

Marianna Bugiani1, Ilja Boor, Barbara van Kollenburg, Nienke Postma, Emiel Polder, Carola van Berkel, Ronald E van Kesteren, Martha S Windrem, Elly M Hol, Gert C Scheper, Steven A Goldman, Marjo S van der Knaap.   

Abstract

Vanishing white matter (VWM) disease is a genetic leukoencephalopathy linked to mutations in the eukaryotic translation initiation factor 2B. It is a disease of infants, children, and adults who experience a slowly progressive neurologic deterioration with episodes of rapid clinical worsening triggered by stress and eventually leading to death. Characteristic neuropathologic findings include cystic degeneration of the white matter with scarce reactive gliosis, dysmorphic astrocytes, and paucity of myelin despite an increase in oligodendrocytic density. To assess whether a defective maturation of macroglia may be responsible for the feeble gliosis and lack of myelin, weinvestigated the maturation status of astrocytes and oligodendrocytes in the brains of 8 VWM patients, 4 patients with other white matter disorders and 6 age-matched controls with a combination of immunocytochemistry, histochemistry, scratch-wound assays, Western blot, and quantitative polymerase chain reaction. We observed increased proliferation and a defect in the maturation of VWM astrocytes. They show an anomalous composition of their intermediate filament network with predominance of the δ-isoform of the glial fibrillary acidic protein and an increase in the heat shock protein αB-crystallin, supporting the possibility that a deficiency in astrocyte function may contribute to the loss of white matter in VWM. We also demonstrated a significant increase in numbers of premyelinating oligodendrocyte progenitors in VWM, which may explain the coexistence of oligodendrocytosis and myelin paucity in the patients' white matter.

Entities:  

Mesh:

Year:  2011        PMID: 21157376      PMCID: PMC4135437          DOI: 10.1097/NEN.0b013e318203ae74

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  57 in total

Review 1.  The oligodendrocyte precursor cell in health and disease.

Authors:  J M Levine; R Reynolds; J W Fawcett
Journal:  Trends Neurosci       Date:  2001-01       Impact factor: 13.837

2.  Olig2 directs astrocyte and oligodendrocyte formation in postnatal subventricular zone cells.

Authors:  Christine A G Marshall; Bennett G Novitch; James E Goldman
Journal:  J Neurosci       Date:  2005-08-10       Impact factor: 6.167

3.  Generation of oligodendroglial progenitors in acute inflammatory demyelinating lesions of the rat brain stem is associated with demyelination rather than inflammation.

Authors:  I C Di Bello; M R Dawson; J M Levine; R Reynolds
Journal:  J Neurocytol       Date:  1999 Apr-May

4.  Intermediate filament protein partnership in astrocytes.

Authors:  C Eliasson; C Sahlgren; C H Berthold; J Stakeberg; J E Celis; C Betsholtz; J E Eriksson; M Pekny
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

5.  Identification, isolation, and promoter-defined separation of mitotic oligodendrocyte progenitor cells from the adult human subcortical white matter.

Authors:  N S Roy; S Wang; C Harrison-Restelli; A Benraiss; R A Fraser; M Gravel; P E Braun; S A Goldman
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

6.  GFAP-positive and myelin marker-positive glia in normal and pathologic environments.

Authors:  C A Dyer; A Kendler; D Jean-Guillaume; R Awatramani; A Lee; L M Mason; J Kamholz
Journal:  J Neurosci Res       Date:  2000-05-01       Impact factor: 4.164

7.  Tracing human oligodendroglial development in vitro.

Authors:  S C Zhang; B Ge; I D Duncan
Journal:  J Neurosci Res       Date:  2000-02-01       Impact factor: 4.164

8.  Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferation in the jimpy mutant.

Authors:  Q Wu; R H Miller; R M Ransohoff; S Robinson; J Bu; A Nishiyama
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

9.  Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.

Authors:  Jason F Talbott; David N Loy; Ying Liu; Mengsheng S Qiu; Mary Bartlett Bunge; Mahendra S Rao; Scott R Whittemore
Journal:  Exp Neurol       Date:  2005-03       Impact factor: 5.330

10.  Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease.

Authors:  M Brenner; A B Johnson; O Boespflug-Tanguy; D Rodriguez; J E Goldman; A Messing
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

View more
  55 in total

Review 1.  Vanishing white matter disease: an Italian case with A638G mutation in exon 5 of EIF2B2 gene, an unusual early onset and a long course.

Authors:  Luisa Sambati; Raffaele Agati; Antonella Bacci; Silvia Bianchi; Sabina Capellari
Journal:  Neurol Sci       Date:  2012-06-23       Impact factor: 3.307

2.  eIF2B Mutations Cause Mitochondrial Malfunction in Oligodendrocytes.

Authors:  Melisa Herrero; Shir Mandelboum; Orna Elroy-Stein
Journal:  Neuromolecular Med       Date:  2019-05-27       Impact factor: 3.843

3.  Stratification of astrocytes in healthy and diseased brain.

Authors:  Alexei Verkhratsky; Robert Zorec; Vladimir Parpura
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

Review 4.  Glial progenitor cell-based treatment of the childhood leukodystrophies.

Authors:  M Joana Osorio; Steven A Goldman
Journal:  Exp Neurol       Date:  2016-05-08       Impact factor: 5.330

5.  Similarities and differences between infantile and early childhood onset vanishing white matter disease.

Authors:  Ling Zhou; Haihua Zhang; Na Chen; Zhongbin Zhang; Ming Liu; Lifang Dai; Jingmin Wang; Yuwu Jiang; Ye Wu
Journal:  J Neurol       Date:  2018-04-16       Impact factor: 4.849

6.  Human pontine glioma cells can induce murine tumors.

Authors:  Viola Caretti; A Charlotte P Sewing; Tonny Lagerweij; Pepijn Schellen; Marianna Bugiani; Marc H A Jansen; Dannis G van Vuurden; Anna C Navis; Ilona Horsman; W Peter Vandertop; David P Noske; Pieter Wesseling; Gertjan J L Kaspers; Javad Nazarian; Hannes Vogel; Esther Hulleman; Michelle Monje; Thomas Wurdinger
Journal:  Acta Neuropathol       Date:  2014-04-29       Impact factor: 17.088

7.  Astrocytes are central in the pathomechanisms of vanishing white matter.

Authors:  Stephanie Dooves; Marianna Bugiani; Nienke L Postma; Emiel Polder; Niels Land; Stephen T Horan; Anne-Lieke F van Deijk; Aleid van de Kreeke; Gerbren Jacobs; Caroline Vuong; Jan Klooster; Maarten Kamermans; Joke Wortel; Maarten Loos; Lisanne E Wisse; Gert C Scheper; Truus E M Abbink; Vivi M Heine; Marjo S van der Knaap
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

Review 8.  White matter astrocytes in health and disease.

Authors:  I Lundgaard; M J Osório; B T Kress; S Sanggaard; M Nedergaard
Journal:  Neuroscience       Date:  2013-11-11       Impact factor: 3.590

9.  An autopsy case of infantile-onset vanishing white matter disease related to an EIF2B2 mutation (V85E) in a hemizygous region.

Authors:  Yukiko Hata; Koshi Kinoshita; Kazushi Miya; Keiichi Hirono; Fukiko Ichida; Koji Yoshida; Naoki Nishida
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

10.  Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination.

Authors:  Su Wang; Janna Bates; Xiaojie Li; Steven Schanz; Devin Chandler-Militello; Corri Levine; Nimet Maherali; Lorenz Studer; Konrad Hochedlinger; Martha Windrem; Steven A Goldman
Journal:  Cell Stem Cell       Date:  2013-02-07       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.